<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Allergan is part of the skin care revolution]]></title><link>http://www.bloggingstocks.com/2008/03/04/allergan-is-part-of-the-skin-care-revolution/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2008/03/04/allergan-is-part-of-the-skin-care-revolution/</guid><comments>http://www.bloggingstocks.com/2008/03/04/allergan-is-part-of-the-skin-care-revolution/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/agn/" rel="tag">Allergan (AGN)</a>, <a href="http://www.bloggingstocks.com/category/stocks-to-buy/" rel="tag">Stocks to Buy</a></p>The choppy/consolidating (or perhaps worse) market conditions sometimes give the impression that growth plays do not exist, but that is not the case, and one growth company worth reviewing is Allergan.<br /><br /><a href="http://finance.aol.com/quotes/allergan-inc/agn/nys?tabs=quotesandnews">Allergan, Inc.</a> (NYSE: <a href="http://finance.aol.com/quotes/allergan-inc/agn/nys?tabs=quotesandnews">AGN</a>) is a leading producer of ophthalmic, neuromuscular and skin care pharmaceuticals, and, via its March 2006 acquisition of Inamed Corp., aesthetic products.<br /><br />Analysts see 10-13% revenue growth in 2008, but with U.S. sales growth dampened by the slow-growth U.S. economy. International markets accounted for about 34% of sales.<br /><br />Concerning Botox, so far there has been no slowdown for therapeutic of cosmetic use, but the latter may record slower growth if U.S. discretionary purchases decline, in the quarters ahead.<p><a href="http://www.bloggingstocks.com/2008/03/04/allergan-is-part-of-the-skin-care-revolution/" rel="bookmark">Continue reading <em>Allergan is part of the skin care revolution</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2008/03/04/allergan-is-part-of-the-skin-care-revolution/">Allergan is part of the skin care revolution</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Tue, 04 Mar 2008 18:39:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2008/03/04/allergan-is-part-of-the-skin-care-revolution/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1131459/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2008/03/04/allergan-is-part-of-the-skin-care-revolution/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>AGN</category><category>Allergan</category><category>Botox</category><category>eye care</category><category>health care</category><category>skin care</category><dc:creator><![CDATA[Joseph Lazzaro]]></dc:creator><pubDate>Tue, 04 Mar 2008 18:39:00 EST</pubDate></item></channel></rss>
